• About us
• Contact

Advertisement

Organisation › Details

Full-Life Technologies Ltd., Heidelberg

Full-Life Technologies Limited ("Full-Life") is a fully integrated global radiotherapeutics company with operations in Belgium, Germany, and China. We seek to own the entire value chain for radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients. The Company plans to attack core issues affecting radiopharmaceuticals today through innovative research that targets the treatments of tomorrow. We are comprised of a team of fast-moving entrepreneurs and scientists with a demonstrated track record in the life sciences, as well as radioisotope research and clinical development. *

 

	Start	2024-01-04 existent
	Group	Full-Life Technologies (Group)
	Industry	UniRDC™ discovery technology
	City	n. a. Heidelberg
		Address record changed: 2024-01-21
Basic data	Employees	n. a.
		* Document for »About Section«: Full-Life Technologies. (1/4/24). "Press Release: Global Radiotherapeutics Company Full-Life Technologies Announces USD $47.3 Million Series B Financing, Prosperity7 Ventures Jointly Leads the Round". Shanghai, Gembloux & Heidelberg.
		Record changed: 2024-12-29

Advertisement

More documents for Full-Life Technologies (Group)

• [1] Full-Life Technologies. (7/17/24). "Press Release: Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Therapeutic Targeting Multiple Solid Tumors". Heidelberg & Seoul....
• [2] Full-Life Technologies. (7/3/24). "Press Release: Full-Life Technologies Granted FDA Fast Track Designation for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer". Heidelberg....
• [3] Full-Life Technologies. (1/4/24). "Press Release: Global Radiotherapeutics Company Full-Life Technologies Announces USD $47.3 Million Series B Financing, Prosperity7 Ventures Jointly Leads the Round". Shanghai, Gembloux & Heidelberg....
• [4] Full-Life Technologies Ltd.. (11/29/22). "Press Release: Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-focused Radiopharmaceutical Pipeline". Brussels, Watchung, NJ & Shanghai....
• [5] Full-Life Technologies Ltd.. (5/26/22). "Press Release: Full-Life Technologies Completes $37 Million (USD) Series A Financing to Accelerate Development of Its Radiopharmaceutical Pipeline and Radiotechnology Production Platform". Shanghai & Brussels....
• [6] Full-Life Technologies Ltd.. (12/21/21). "Press Release: Full-Life Technologies Launches with $10M Seed Round Financing to Advance Its Nuclear Technology & Nuclear Medicines Businesses". Belgium & Shanghai....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.